← Eichor
Study identifier: NCT06438419 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency Range

Condition: Parkinson Disease · Hyperkinesis · Hypokinesia  ·  Sponsor: University Hospital, Bordeaux

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Expression of hypokinetic and hyperkinetic motor symptoms in Parkinson's disease (PD) is associated with pathological synchronous oscillations of neuronal activity (local field potential/LFP) in the cortico-subcortical network with a wide frequency range. In the present project, we propose to study cortico-subcortical oscillations and their synchronization in patients operated for PD (subthalamic deep brain stimulation (STN-DBS)) during distinct pharmacological and stimulation conditions (hypokinetic and hyperkinetic), using a simple motor task.

This description comes directly from the study's public registry record.

Talk to the study team

GUEHL Dominique, Pr  ·  5 57 82 12 42  ·  dominique.guehl@chu-bordeaux.fr

Claire BRANDET  ·  claire.brandet@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Bordeaux University HospitalBordeaux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06438419